DOI QR코드

DOI QR Code

Differences in the Levels of Gastric Cancer Risk Factors Between Nanjing and Minqing Counties, China

  • Xie, Xiang-Quan (Fujian Center for Disease Control and Prevention) ;
  • Zheng, Kui-Cheng (Fujian Center for Disease Control and Prevention) ;
  • Wu, Bing-Shan (Fujian Center for Disease Control and Prevention) ;
  • Chen, Tie-Hui (Fujian Center for Disease Control and Prevention) ;
  • Lai, Shan-Rong (Fujian Center for Disease Control and Prevention) ;
  • Lin, Zai-Sheng (Fujian Center for Disease Control and Prevention) ;
  • Aoki, Kazuo (Department of Public Health and Hygiene, Graduate School of Medicine, University of the Ryukyus)
  • 투고 : 2014.05.08
  • 심사 : 2014.09.04
  • 발행 : 2014.09.30

초록

Objectives: In Fujian Province, China, gastric cancer is one of the leading causes of mortality among all malignant tumors. Nanjing county and Minqing county are located in inland Fujian and have similar general demographics. However, the adjusted mortality rate of gastric cancer in Minqing was found to be much higher than that in Nanjing. We sought to explore factors associated with this increased risk of gastric cancer between the two counties. Methods: We recruited 231 and 224 residents from Nanjing and Minqing, respectively, and analyzed differences between their dietary habits, Helicobacter pylori infection rates, and concentrations of serum pepsinogen I, pepsinogen II, gastrin-17, and ratio of pepsinogen I:II. Results: Subjects in Minqing had more first-degree relatives who had been diagnosed with upper gastrointestinal tumor, more unhealthy dietary habits, a higher Helicobacter pylori positive rate, and greater proportion of abnormal serum gastrin-17 than those in Nanjing did. Conclusions: The factors that differed between these two counties might indicate that residents in Minqing have a higher risk for developing gastric cancer than those in Nanjing do.

키워드

참고문헌

  1. International Agency for Research on Cancer; World Health Organization. The GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide 2012 [cited 2014 Sep 16]. Available from: http://globocan.iarc.fr/.
  2. Yuan SJ, Zhou TS. Health of the population in Fujian province. Fujian: Fujian Center for Disease Control and Preventio; 1997, p. 28-30 (Chinese).
  3. Kawasaki K, Kanemitsu K, Yasuda T, Kamigaki T, Kuroda D, Kuroda Y. Family history of cancer in Japanese gastric cancer patients. Gastric Cancer 2007;10(3):173-175. https://doi.org/10.1007/s10120-007-0427-6
  4. Ren JS, Kamangar F, Forman D, Islami F. Pickled food and risk of gastric cancer: a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomarkers Prev 2012;21(6):905-915. https://doi.org/10.1158/1055-9965.EPI-12-0202
  5. Peleteiro B, La Vecchia C, Lunet N. The role of Helicobacter pylori infection in the web of gastric cancer causation. Eur J Cancer Prev 2012;21(2):118-125. https://doi.org/10.1097/CEJ.0b013e32834a7f66
  6. Shanmugam KR, Mallikarjuna K, Nishanth K, Kuo CH, Reddy KS. Protective effect of dietary ginger on antioxidant enzymes and oxidative damage in experimental diabetic rat tissues. Food Chem 2011;124(4):1436-1442. https://doi.org/10.1016/j.foodchem.2010.07.104
  7. Sasazuki S, Tamakoshi A, Matsuo K, Ito H, Wakai K, Nagata C, et al. Green tea consumption and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2012;42(4)335-346. https://doi.org/10.1093/jjco/hys009
  8. Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels: "ABC method". Proc Jpn Acad Ser B Phys Biol Sci 2011;87(7):405-414. https://doi.org/10.2183/pjab.87.405
  9. Inoue K. We can tell the "degree of health" of the stomach (gastric cancer risk) by blood test. Gastro Health Now 2010;12:1-3 (Japanese).
  10. Iijima K, Abe Y, Kikuchi R, Koike T, Ohara S, Sipponen P, et al. Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol 2009;15(7):853-859. https://doi.org/10.3748/wjg.15.853
  11. Palli D, Galli M, Caporaso NE, Cipriani F, Decarli A, Saieva C, et al. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev 1994;3(1):15-18.
  12. La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992;70(1):50-55. https://doi.org/10.1002/1097-0142(19920701)70:1<50::AID-CNCR2820700109>3.0.CO;2-I
  13. Lissowska J, Groves FD, Sobin LH, Fraumeni JF Jr, Nasierowska-Guttmejer A, Radziszewski J, et al. Family history and risk of stomach cancer in Warsaw, Poland. Eur J Cancer Prev 1999;8(3):223-227. https://doi.org/10.1097/00008469-199906000-00010
  14. Shin CM, Kim N, Yang HJ, Cho SI, Lee HS, Kim JS, et al. Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol 2010;44(2): e34-e39. https://doi.org/10.1097/MCG.0b013e3181a159c4
  15. Zhang ZW, Farthing MJ. The roles of vitamin C in Helicobacter pylori associated gastric carcinogenesis. Chin J Dig Dis 2005;6(2):53-58. https://doi.org/10.1111/j.1443-9573.2005.00194.x
  16. Kono S, Ikeda M, Tokudome S, Kuratsune M. A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn J Cancer Res 1988;79(10):1067-1074. https://doi.org/10.1111/j.1349-7006.1988.tb01528.x
  17. Liu AM, Zhao JK, Zhang ZF. A case-control study on green tea's effect on the incidence of gastric cancer in residents of Dafeng City. China Cancer 2010;19:585-588 (Chinese).
  18. Zhou MH. Algae chemistry. Beijing: Science Press; 1997, p. 208 (Chinese).
  19. Cheng XL, Liu Q, Peng YB, Qi LW, Li P. Steamed ginger (Zingiber officinale): changed chemical profile and increased anticancer potential. Food Chem 2011;129(4):1785-1792. https://doi.org/10.1016/j.foodchem.2011.06.026
  20. Oboh G, Akinyemi AJ, Ademiluyi AO. Antioxidant and inhibitory effect of red ginger (Zingiber officinale var. Rubra) and white ginger (Zingiber officinale Roscoe) on Fe(2+) induced lipid peroxidation in rat brain in vitro. Exp Toxicol Pathol 2012;64(1-2):31-36. https://doi.org/10.1016/j.etp.2010.06.002
  21. Fei S, Xiao S. Diet and gastric cancer: a case-control study in Shanghai urban districts. Chin J Gastroenterol 2003;(3):143-147.
  22. Li YM, Chen LR, Xie QJ. Detection of nitroso compounds in pickles and analysis on the reason leading to high incidence of gastric cancer in Wuwei City. Anal Test TechnolInstrum 2003;2:88-90 (Chinese).
  23. Yu SZ, Ma LN, Cai L. Risk and protective factors for upper digestive tract cancer and molecular epidemiological studies in Chinese two regions. Chin J Clin 2007;1:88-92 (Chinese).
  24. Forman D. The etiology of gastric cancer: relevance to human cancer of N-nitroso compounds, tobacco, smoking and mycotoxins. Adv Exp Med Biol 1996;206:7-34.
  25. Hu PJ, Hu FL. Summary of Chinese Medical Association's fourth national academic conference on H. pylori. Chin J Dig 2005;25:698-699 (Chinese).
  26. Mitchell HM. The epidemiology of Helicobacter pylori. Curr Top Microbiol Immunol 1999;241:11-30.
  27. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology: a study in relatives of patients with pernicious anemia. Gastroenterology 1982;83(1 Pt 2):204-209.
  28. Sipponen P, Ranta P, Helske T, Kaariainen I, Maki T, Linnala A, et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002;37(7):785-791. https://doi.org/10.1080/gas.37.7.785.791
  29. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35(2):173-177. https://doi.org/10.1002/ijc.2910350206

피인용 문헌

  1. HLA‐DQB1*03 genotype and perioperative blood transfusion are not conducive to the prognosis of patients with gastric cancer vol.32, pp.7, 2014, https://doi.org/10.1002/jcla.22443
  2. Poor expression of microRNA‐135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1‐mediated MAPK signalin vol.33, pp.3, 2014, https://doi.org/10.1096/fj.201800618rrr
  3. Changing trends of clinicopathologic features and survival duration after surgery for gastric cancer in Northeast China vol.12, pp.10, 2020, https://doi.org/10.4251/wjgo.v12.i10.1119